Karen A. Licitra - Jun 25, 2021 Form 4 Insider Report for SI-BONE, Inc. (SIBN)

Role
Director
Signature
/s/ Michael A. Pisetsky, Attorney-in-Fact for Karen A. Licitra
Stock symbol
SIBN
Transactions as of
Jun 25, 2021
Transactions value $
-$622,533
Form type
4
Date filed
6/28/2021, 05:12 PM
Next filing
Jul 23, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SIBN Common Stock Options Exercise $44.5K +10.3K +117.05% $4.32* 19.1K Jun 25, 2021 Direct
transaction SIBN Common Stock Options Exercise $48K +11.1K +58.19% $4.32* 30.2K Jun 25, 2021 Direct
transaction SIBN Common Stock Sale -$370K -11.1K -36.79% $33.33 19.1K Jun 25, 2021 Direct F1
transaction SIBN Common Stock Sale -$345K -10.3K -53.93% $33.48 8.8K Jun 25, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SIBN Stock Option (Right to Buy) Options Exercise $0 -11.1K -100% $0.00* 0 Jun 25, 2021 Common Stock 11.1K $4.32 Direct F3
transaction SIBN Stock Option (Right to Buy) Options Exercise $0 -10.3K -100% $0.00* 0 Jun 25, 2021 Common Stock 10.3K $4.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Karen A. Licitra is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.19 to $33.57, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnotes.
F2 The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.29 to $33.78, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnotes.
F3 The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.